What is the recommended dose of ketamine (intravenous anesthetic) for procedural sedation in adult and pediatric patients, considering factors such as weight, age, and medical history, including cardiovascular disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketamine Dosing for Procedural Sedation

For procedural sedation in adults, administer ketamine 1.5-2 mg/kg IV (or 4 mg/kg IM if IV access unavailable), and in pediatric patients use 0.75-2.0 mg/kg IV (or 4 mg/kg IM), with continuous monitoring of vital signs and airway status. 1

Intravenous Dosing

Adult Patients

  • Administer 1.5-2 mg/kg IV as the initial bolus dose 1, 2
  • This dosing range is significantly more effective than lower doses, with only 5.5% of patients requiring additional doses compared to 54% when using 1.0 mg/kg 1, 3
  • Onset of action occurs within 30-96 seconds, allowing for rapid procedural intervention 1
  • Duration of effect is 10-15 minutes, with average recovery time of approximately 84 minutes 4, 1

Pediatric Patients

  • Use 0.75-2.0 mg/kg IV for children aged 1 month to 20 years 4
  • Age-adjusted dosing may be required: younger children need slightly higher doses (2.125 mg/kg for 2-year-olds vs 1.5 mg/kg for adults) 3
  • Inadequate sedation occurs in only 3.1% of pediatric patients when combined with midazolam 4

Intramuscular Dosing

When to Use IM Route

  • Administer 4 mg/kg IM when IV access is unavailable or impractical 1, 2
  • Provides 100% adequacy of sedation to complete procedures 2
  • Onset of action within 3-4 minutes 1, 2
  • Recovery time averages approximately 90 minutes 1

Pediatric IM Dosing

  • Use 4 mg/kg IM with repeat doses of 2-4 mg/kg allowed after 5-10 minutes if needed 1
  • When combined with atropine 0.01 mg/kg, results in faster onset (3 minutes vs 18 minutes) and shorter discharge time compared to other sedatives 1

Combination Therapy with Midazolam

Rationale for Adding Midazolam

  • Consider adding midazolam 0.05-0.2 mg/kg IV to reduce emergence reactions 4, 1
  • Emergence phenomena (floating sensations, vivid dreams, hallucinations, delirium) occur in 10-30% of adults receiving ketamine alone 4, 5
  • Midazolam reduces recovery agitation from 35.7% to 5.7% in patients over 10 years old 1

Combination Dosing Protocol

  • Administer midazolam 0.05-0.1 mg/kg IV followed by ketamine 1.5-2 mg/kg IV 1, 6
  • Alternative: midazolam 0.07 mg/kg followed by ketamine 2 mg/kg provides effective procedural sedation in adults 4, 1
  • This combination provides superior sedation with fewer respiratory complications than fentanyl/midazolam regimens 1, 6

Alternative Dosing Strategies

Top-Up Technique for Intermittent Pain

  • Use a smaller initial bolus (0.75-1.0 mg/kg) with a subsequent half-dose "top-up" at 8 minutes 3
  • Achieves same sedation level as single large dose but with earlier recovery 3
  • Better suited for procedures with intermittent painful stimuli 3

Infusion Technique for Continuous Pain

  • Initial bolus: 0.25-0.35 mg/kg IV (age-adjusted) 3
  • Followed by infusion: 2.5-3.5 mg/kg/hour for 15 minutes 3
  • Provides more even sedation level and rapid recovery (20 minutes to drowsy state) 3
  • Better suited for procedures requiring continuous analgesia 3

Cardiovascular Considerations

Hemodynamic Effects

  • Ketamine produces dose-dependent increases in heart rate, blood pressure, and cardiac output through sympathetic nervous system stimulation 4
  • These effects increase myocardial oxygen demand 7

Absolute Contraindications

  • Avoid ketamine in patients with:
    • Ischemic heart disease 4, 1, 2
    • Cerebrovascular disease 4, 1, 2
    • Uncontrolled hypertension 4, 2
    • Active psychosis 1, 2, 6
    • Severe hepatic dysfunction 1, 2
    • Elevated intracranial or intraocular pressure 1, 2

Safety Data in Older Adults

  • In patients over 50 years, new onset ischemia on ECG occurred in only 9.7% (3/31 patients), with no statistically or clinically significant impact on patient disposition 7
  • Consider using the lowest possible dose to obtain adequate sedation in patients with cardiovascular risk factors 7

Monitoring Requirements

Essential Monitoring Parameters

  • Continuous pulse oximetry, heart rate, and blood pressure monitoring throughout sedation 1, 2, 6
  • Capnography when available 1
  • Vital signs documented at least every 5 minutes during deep sedation 1
  • Maintain oxygen saturation >93% on room air 1

Equipment Preparation

  • Airway equipment must be immediately available 2
  • Bag-valve-mask apparatus ready for potential respiratory support 2
  • Naloxone should be available if opioids are co-administered 4

Adverse Events and Management

Respiratory Complications

  • Hypoxemia occurs in 1.6-7.3% of patients, typically transient and responsive to supplemental oxygen 1
  • Bag-valve-mask ventilation required in approximately 2% of cases 1
  • Brief apnea around time of injection is common 5
  • Laryngospasm is rare (0.9-1.4% of cases) 2, 6
  • Only 1% of pediatric patients experience transient hypoxemia when ketamine is combined with midazolam 4

Emergence Reactions

  • Recovery agitation occurs in 17.6% of cases overall, with moderate-to-severe agitation in 1.6% 1, 2
  • Dysphoric emergence occurs in 10-20% of cases 2, 5
  • Associated with higher ASA status and decreasing age in pediatrics 1
  • Midazolam effectively prevents and manages these reactions 4, 5

Gastrointestinal Effects

  • Emesis without aspiration occurs in 6.7% of cases 1, 2
  • Associated with increasing age in pediatric patients 1
  • Nausea occurs in 4-5% of patients 6

Unique Safety Profile

  • Ketamine does not depress airway or cardiovascular reflexes even when administered at doses 5-100 times greater than intended 4
  • When inadvertently administered to 9 children at doses 5-100 times intended, only brief respiratory depression was observed 4
  • No episodes of clinically significant respiratory depression or cardiovascular instability in large pediatric series 1

Clinical Pearls

Advantages Over Other Agents

  • Ketamine possesses both analgesic and sedative properties, unlike most sedation agents 4
  • Preserves pharyngeal reflexes and stimulates cardiovascular tone 5
  • Superior respiratory safety profile compared to fentanyl/midazolam combinations (6% vs 24% hypoxemia, P=0.001) 6

Patient Satisfaction

  • Patient satisfaction consistently high: 92-99% rate experience as "excellent" or "good" 2, 6
  • Physician satisfaction similarly high: 88% rate as "excellent" or "good" 6
  • All patients receiving appropriate dosing achieve adequate sedation for procedures 1, 6

Recovery Considerations

  • Recovery time with IV ketamine averages 84 minutes (range 22-215 minutes) 1
  • Time to return to baseline mental status: median 14 minutes with ketamine vs 5 minutes with propofol 8
  • Recovery agitation more frequent with ketamine than propofol (36% vs 8%) 8

References

Guideline

Ketamine Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Intramuscular Ketamine Dosing for Procedural Sedation in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse events associated with ketamine for procedural sedation in adults.

The American journal of emergency medicine, 2008

Guideline

Ketamine Administration for Pediatric Bone Fracture Reduction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Randomized clinical trial of propofol versus ketamine for procedural sedation in the emergency department.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2010

Related Questions

What is the recommended dose of ketamine (Ketamine) for maintaining sedation?
What is the recommended dose of ketamine (intravenous or intramuscular anesthetic) for sedation in a 28kg child?
What is the recommended intramuscular (IM) dose of Ketamine for procedural sedation in adults?
What is the recommended infusion rate for maintaining sedation with ketamine (intravenous anesthetic agent)?
What is the recommended dose of ketamine (ketamine hydrochloride) for sedation in pediatric (peds) patients?
Is it medical malpractice if a diabetic patient with abdominal pain, nausea, poor oral intake, acid reflux, dizziness, and fatigue, diagnosed with early acute appendicitis, was not investigated for ketosis or metabolic acidosis despite abnormal lab results (hyperchloremia, metabolic acidosis, elevated anion gap), and was discharged after surgery with severe metabolic acidosis, only to return to the ER with worsening condition?
What is the recommended approach for conservative treatment of uncomplicated appendicitis in an otherwise healthy patient?
What type of anemia is present in an adult patient with a history of renal cell carcinoma and potential chronic kidney disease, presenting with mild anemia, hypochromia, and microcytosis, as indicated by laboratory values of low hemoglobin (Hb), low hematocrit (Hct), low mean corpuscular hemoglobin concentration (MCHC), low mean corpuscular hemoglobin (MCH), and elevated red blood cell distribution width (RDW)?
What is the recommended treatment for a female in her 20s with suspected Turner syndrome (TS), presenting with undeveloped female organs and breasts?
Can tranexamic acid (TXA) cause thromboembolism in patients with a history of bleeding disorders or those at high risk for blood clots?
Is adding levofloxacin (a fluoroquinolone antibiotic) to the current regimen of piperacillin/tazobactam and clindamycin appropriate for a post-amputation patient who has developed pneumonia while already on these antibiotics?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.